GlassScriptPhysician profile
Thomas Michael Shimshak
NPI 1467567941
$30,202.81
in general payments reported to CMS, 2019-2025
22 companies · $202 in 2025
The $202 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $181 · 2021: $481 · 2022: $574 · 2023: $702 · 2024: $612 · 2025: $202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,415 · Gift: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.96 |
| Gift | $100.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $27,623.82 | 2019-2024 | Eluvia |
| Abbott Laboratories | $696.14 | 2020-2024 | Gallant, Jot Dx, Merlin@Home |
| Abiomed | $614.95 | 2022-2025 | Impella |
| Endologix LLC | $397.47 | 2021-2022 | |
| Medtronic, INC. | $160.31 | 2021-2023 | |
| Surmodics, INC. | $136.67 | 2024-2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Penumbra, INC. | $97.52 | 2019-2023 | Indigo System |
| Cardiovascular Systems INC. | $92.50 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $62.65 | 2019-2022 | |
| Inari Medical, INC. | $56.11 | 2021 | |
| Cook Medical LLC | $46.87 | 2019 | |
| Shockwave Medical, INC | $38.80 | 2022 | |
| Cvrx, INC. | $23.46 | 2020 | |
| Novartis Pharmaceuticals Corporation | $21.13 | 2022 | |
| Biotronik INC. | $20.91 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17.28 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.25 | 2025 | Lifevest |
| Pfizer INC. | $16.72 | 2025 | |
| Terumo Medical Corporation | $16.71 | 2023 | Optitorque |
| W. L. Gore & Associates, INC. | $16.08 | 2019 | |
| Inspiremd LTD | $15.00 | 2025 | Cguard Prime Carotid Stent System |
| Medtronic Vascular, INC. | $14.46 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Shimshak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.